NEW YORK,Dec. 3, 2025/PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:[BDMD](#financial-modal)) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the appointment of Mark Saxton as Chief Executive Officer of its U.S. subsidiary.Mr. Saxton is a seasoned medical device executive with more than 25 years of commercial leadership experience, including a decade advancing intravascular RF ablation technologies. He will lead a ...

Core Insights - Baird Medical Investment Holdings Ltd. has successfully completed its first Microwave Ablation (MWA) procedure in Bangladesh, marking a significant advancement in non-surgical cancer therapies in the region [1][2][3] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on the research and development of surgical robotic systems and innovative surgical instruments [4] - The company is FDA 510(k)-certified and has its solutions utilized in over 30 prestigious hospitals and clinics across the United States, including Johns Hopkins Hospital and Weill Cornell Medicine [4] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries worldwide [4] Recent Developments - The first MWA procedure in Bangladesh was led by Dr. Mofazzal Sharif Rasel, successfully treating a 65-year-old patient with a 6 cm liver tumor, who is reported to be recovering well [2][3] - The completion of this procedure signifies a new era of access to advanced treatment options for patients in South Asia, reflecting growing global confidence in Baird Medical's MWA technology [3] Strategic Goals - Baird Medical aims to strengthen its global presence through strategic collaborations with leading clinicians and medical institutions, enhancing access to innovative tumor treatment solutions [3]

Core Insights - Baird Medical Investment Holdings Ltd. is a global leader in minimally invasive Microwave Ablation (MWA) technology and has successfully participated in a workshop in Malaysia aimed at advancing MWA skills among local physicians [1][3]. Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative surgical instruments [4]. - The company is FDA 510(k)-certified and its solutions are utilized in over 30 prestigious hospitals and clinics in the United States, including Johns Hopkins Hospital and Weill Cornell Medicine [4]. - Baird Medical is the market leader in China for thyroid microwave ablation devices and consumables, with a growing commercial presence in over 20 countries [4]. Workshop Details - The workshop held on October 1-2, 2025, featured leading surgeons and endocrinologists, providing hands-on training and complex case discussions [2]. - The program was led by distinguished faculty, including Dr. Shuhang Xu from Nanjing University and local surgeons from HCTM [2]. Commitment to Innovation - Baird Medical's participation in the workshop underscores its commitment to advancing medical technologies and ensuring their effective adoption globally [3]. - The company aims to empower physicians to deliver MWA treatments safely and effectively, marking a significant step in the global expansion of this therapy [3].

Core Insights - Baird Medical Investment Holdings Ltd. participated in the 3rd International Workshop on Thermal Ablation of Thyroid Tumor and Hyperparathyroidism, highlighting its leadership in minimally invasive Microwave Ablation (MWA) technology [1][3][4] - The workshop, chaired by Prof. Ming'an Yu, served as a platform for experts to share clinical experiences and advanced techniques in the field [2] - Baird Medical emphasizes the importance of collaboration in advancing MWA innovation and improving patient care [4] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative surgical instruments [6] - The company is FDA 510(k)-certified and has its solutions utilized in over 30 prestigious hospitals in the U.S., including Johns Hopkins Hospital and Columbia University Medical Center [6] - Baird Medical is the market leader in China for thyroid microwave ablation devices and is expanding its presence in over 20 countries [6]

Core Insights - Baird Medical Investment Holdings Ltd. is enhancing clinical proficiency in Microwave Ablation (MWA) technology through sponsored training programs at leading U.S. academic medical centers [1][2][3] Group 1: Training Initiatives - The company has conducted intensive training sessions at Tulane University and Columbia University, focusing on MWA for thyroid nodule treatment [1][2] - Notable training sessions included five live cases led by Dr. Emad Kandil at Tulane University and specialized courses at Columbia University by Dr. Jennifer Kuo, demonstrating the effectiveness of Baird's MWA system [2][3] Group 2: Commitment to Clinical Excellence - Baird Medical emphasizes its mission to ensure clinicians are well-trained to achieve optimal patient outcomes, collaborating with top institutions to set high standards in care [3] - The company is dedicated to expanding educational initiatives and partnerships with key opinion leaders to promote MWA as a primary treatment for thyroid disease [3] Group 3: Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatments, focusing on surgical robotic systems and innovative surgical instruments [4] - The company is FDA 510(k)-certified and has its solutions utilized in over 30 prestigious hospitals across the U.S., including Johns Hopkins Hospital and Columbia University Medical Center [4] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its presence in over 20 countries globally [4]